Panbela Therapeutics Q1 EPS $(0.27) Misses $(0.25) Estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 17.39 percent decrease over losses of $(0.23) per share

byBill Haddad

May 12, 2022

1 minute read

SkyBridge Capital Is Raising $250M For An Algorand Crypto Fund

By Samyuktha Sriram

Today, 4:56 AM

Anthony Scaramucci’s SkyBridge Capital has over $700 million in crypto and plans to further expand its crypto offerings.

UBER

‘Ukraine Is Buying Bulletproof Vests and Night-Vision Goggles Using Crypto’ -CoinDesk Report

By Benzinga Newsdesk

Today, 4:56 AM

https://www.coindesk.com/policy/2022/03/07/ukraine-is-buying-bulletproof-vests-and-night-vision-goggles-using-crypto/

COIN

News

MultiMetaVerse, Model Performance Acquisition Complete Business Combination

By Michael Horton

Today, 4:56 AM

MultiMetaVerse Inc., an animation and entertainment company devoted to establishing an open community for its global users and to providing high-quality and immersive entertainment experiences, and Model Performance

MPAC

Dow Dips 300 Points; Snap Shares Plunge

By Lisa Levin

Today, 4:56 AM

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500 also fell, dropping, 0.41% to 4,059.70.

BGXX

Panbela Therapeutics Q1 EPS $(0.27) Misses $(0.25) Estimate

Related Posts

SkyBridge Capital Is Raising $250M For An Algorand Crypto Fund

‘Ukraine Is Buying Bulletproof Vests and Night-Vision Goggles Using Crypto’ -CoinDesk Report

MultiMetaVerse, Model Performance Acquisition Complete Business Combination

Dow Dips 300 Points; Snap Shares Plunge